Jemal, A, Siegel, R, Ward, et al. Cancer Statistics, 2009. CA Cancer J Clin, 2009; 59:225- 249. 40. Kantoff P, Glode L, Tannenbaum S, et al. Randomized, double- blind, vector -controlled study of targeted immunotherapy in patients with hormone- refractory prostate cancer [abstract]. J Clin Oncol 2006;24(18S):2501. 41. Kantoff PW, Schuetz TJ, Blumenstein BA, et al . Overall survival analysis of a Phase II randomized controlled trial (RCT) of a poxviral -based PSA -targeted immunotherapy in metastatic castration- resistant prostate cancer. J Clin Oncol 2010 Mar 1 (28):1109- 1105. 42. Kantoff PW, Higano CS, Shore ND, et al. Sipuleucel -T immunotherapy for castration-r esistant prostate cancer. N Engl J Med 2010: 363 (5): 411- 422.